Table 1.
Baseline patient demographics and disease characteristics (safety population)
| Ferumoxytol (n = 997) | Ferric carboxymaltose (n = 1000) | |
|---|---|---|
| Age, years, mean (SD) | 55.6 (17.3) | 54.8 (17.0) |
| Female, n (%) | 743 (74.5) | 776 (77.6) |
| Race, n (%) | ||
| White | 711 (71.3) | 715 (71.5) |
| Black | 237 (23.8) | 232 (23.2) |
| Asian | 32 (3.2) | 29 (2.9) |
| American Indian/Alaskan Native | 6 (0.6) | 3 (0.3) |
| Other | 8 (0.8) | 15 (1.5) |
| Not reported | 3 (0.3) | 4 (0.4) |
| Weight, kg, mean (SD) | 84.3 (24.9) | 85.8 (26.0) |
| Hemoglobin, g/dL, mean (SD) | 10.4 (1.5) | 10.4 (1.5) |
| Serum phosphate, mg/dL, mean (SD) | 3.7 (0.6)a | 3.7 (0.6)b |
| Transferrin saturation, %, mean (SD) | 13.9 (28.4) | 13.9 (25.0) |
| Serum ferritin, ng/mL, mean (SD) | 54.3 (115.4) | 55.1 (120.2) |
a
SI units: 1.2 (0.2) mmol/L.
b
SI units: 1.2 (0.2) mmol/L.
SD, standard deviation.